Montefusco E - Search Results

1

Acute myeloblastic leukemia secondary to myelodysplasia (MDS-AML): a comparison of remission induction with three drugs versus standard two-drugs induction.

Latagliata R, Breccia M, Pulsoni A, Aloe Spiriti MA, D'Elia GM, Spadea A, Montefusco E, Luzi G, Betrò P, Petti MC. Latagliata R, et al. Among authors: montefusco e. Leuk Lymphoma. 2000 Feb;36(5-6):539-41. doi: 10.3109/10428190009148402. Leuk Lymphoma. 2000. PMID: 10784399

2

A phase II study of VP-16, intermediate-dose Ara-C and carboplatin (VAC) in advanced acute myelogenous leukemia and blastic chronic myelogenous leukemia.

Amadori S, Picardi A, Fazi P, Testi AM, Petti MC, Montefusco E, Mandelli F. Amadori S, et al. Among authors: montefusco e. Leukemia. 1996 May;10(5):766-8. Leukemia. 1996. PMID: 8656669 Clinical Trial.

3

Polycythemia vera treated with pipobroman as single agent: low incidence of secondary leukemia in a cohort of patients observed during 20 years (1971-1991).

Petti MC, Spadea A, Avvisati G, Spadea T, Latagliata R, Montefusco E, Cosenza M, Malagnino F. Petti MC, et al. Among authors: montefusco e. Leukemia. 1998 Jun;12(6):869-74. doi: 10.1038/sj.leu.2401045. Leukemia. 1998. PMID: 9639413

4

Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma.

Montefusco E, Fazi F, Cordone I, Ariola C, Nanni M, Spadea A, Spiriti MA, Fenu S, Mandelli F, Petti MC. Montefusco E, et al. Leuk Lymphoma. 2001 Feb;40(5-6):671-4. doi: 10.3109/10428190109097666. Leuk Lymphoma. 2001. PMID: 11426540

5

High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.

Petti MC, Tafuri A, Latagliata R, Aloe Spiriti MA, Montefusco E, Mancini M, Meloni G, Petrucci MT, Spadea A, Redi R, Alimena G, Mandelli F. Petti MC, et al. Among authors: montefusco e. Ann Hematol. 2003 Aug;82(8):476-480. doi: 10.1007/s00277-003-0693-2. Epub 2003 Jun 26. Ann Hematol. 2003. PMID: 12835916

6

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival.

Breccia M, Luciano L, Latagliata R, Castagnetti F, Ferrero D, Cavazzini F, Trawinska MM, Annunziata M, Stagno F, Tiribelli M, Binotto G, Crisà E, Musto P, Gozzini A, Cavalli L, Montefusco E, Iurlo A, Russo S, Cedrone M, Rossi AR, Pregno P, Endri M, Spadea A, Molica M, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Cambrin GR, Isidori A, Sica S, Abruzzese E, Speccha G, Rosti G, Alimena G. Breccia M, et al. Among authors: montefusco e. Leuk Res. 2014 Oct;38(10):1173-6. doi: 10.1016/j.leukres.2014.06.020. Epub 2014 Jul 7. Leuk Res. 2014. PMID: 25047978

7

Elderly patients with Ph+ chronic myelogenous leukemia (CML): results of imatinib mesylate treatment.

Latagliata R, Breccia M, Carmosino I, Sarlo C, Montefusco E, Mancini M, Natalino F, Chistolini A, De Cuia R, Russo E, Morano GS, Biondo F, Spadea A, Mandelli F, Alimena G. Latagliata R, et al. Among authors: montefusco e. Leuk Res. 2005 Mar;29(3):287-91. doi: 10.1016/j.leukres.2004.08.002. Leuk Res. 2005. PMID: 15661264 Clinical Trial.

8

In vitro purging with BCR-ABL antisense oligodeoxynucleotides does not prevent haematologic reconstitution after autologous bone marrow transplantation.

de Fabritis P, Amadori S, Petti MC, Mancini M, Montefusco E, Picardi A, Geiser T, Campbell K, Calabretta B, Mandelli F. de Fabritis P, et al. Among authors: montefusco e. Leukemia. 1995 Apr;9(4):662-4. Leukemia. 1995. PMID: 7536864

9

Erythropoietin treatment of idiopathic myelofibrosis.

Aloe Spiriti M, Latagliata R, Avvisati G, Battistel V, Montefusco E, Spadea A, Petti MC. Aloe Spiriti M, et al. Among authors: montefusco e. Haematologica. 1993 Nov-Dec;78(6):371-3. Haematologica. 1993. PMID: 8175031

10

Treatment of high-risk myelodysplastic syndromes with lymphoblastoid alpha interferon.

Petti MC, Latagliata R, Avvisati G, Spiriti MA, Montefusco E, Spadea A, Mandelli F. Petti MC, et al. Among authors: montefusco e. Br J Haematol. 1996 Nov;95(2):364-7. doi: 10.1046/j.1365-2141.1996.d01-1911.x. Br J Haematol. 1996. PMID: 8904893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters